OviTex – Nucleus Medical Media
OviTex® Versterkte Weefsel Matrix · GD Medical
TELA Bio: Tailwinds In Hernia Repair Market, Promising Clinical Data (TELA) | Seeking Alpha
Bravo 2-Year Study | TELABIO-Science.Value.Innovation
Premier Contract & Resources | TELABIO-Science.Value.Innovation
Reinforced Bioscaffolds | AROA
OviTex® Versterkte Weefsel Matrix · GD Medical
In-vivo evaluation of a reinforced ovine biologic: a comparative study to available hernia mesh repair materials | SpringerLink
High magnification histology of all implants 4, 12, and 24 weeks, scale... | Download Scientific Diagram
TELA Bio - Hernia surgeon Dr. Stephen Ferzoco tested our... | Facebook
Bravo 2-Year Study | TELABIO-Science.Value.Innovation
Polymers | Free Full-Text | A Polymer-Biologic Hybrid Hernia Construct: Review of Data and Early Experiences
Comparison of mechanical properties and host tissue response to OviTex™ and Strattice™ surgical meshes | Hernia
In-Vivo Evaluation of a Reinforced Ovine Biologic for Plastic and Reconstructive Procedures in a Non-human Primate Model of Soft Tissue Repair
Comparison of mechanical properties and host tissue response to OviTex™ and Strattice™ surgical meshes | Hernia
TELA Bio to market large Size OviTex RBS
Minimizing Retained Foreign Body In Hernia Repair Using A Novel Technique: Reinforced Biologic Augmented Repair (Rebar)
Comparison of mechanical properties and host tissue response to OviTex™ and Strattice™ surgical meshes | Hernia
New Data on OviTex in Hernia Repair Applications - OR Today
JCM | Free Full-Text | A Prospective, Single Arm, Multi-Center Study Evaluating the Clinical Outcomes of Ventral Hernias Treated with OviTex® 1S Permanent Reinforced Tissue Matrix: The BRAVO Study 12-Month Analysis
TELA Bio | OviTex Reinforced Tissue Matrix
Bravo 2-Year Study | TELABIO-Science.Value.Innovation
TELA Bio, Inc.
TELA Bio Stock Plugging Away (NASDAQ:TELA) | Seeking Alpha
